Top Markets
Coin of the day
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Classificação em ações #20442
Fusion Antibodies plc, a contract research organization, engages in the... Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
Preço da ação
$0.16328419
Valor de mercado
$204.14K
Variação (1 dia)
4.35%
Variação (1 ano)
102.45%
País
GB
Negociar Fusion Antibodies plc (FAB)

Categoria

EPS de Fusion Antibodies plc (FAB)
EPS em September 2025 TTM: $-0.02
De acordo com os últimos relatórios financeiros e o preço das ações da Fusion Antibodies plc, o EPS atual da empresa (TTM) é $-0.02. No final de 2024, a empresa teve um EPS de $-0.05, uma diminuição em relação a ao EPS de 2023, que foi de $-0.12.
Histórico de EPS da Fusion Antibodies plc de 2013 até 2026
EPS no final de cada ano
Ano EPS Alterar
2026 (TTM) $-0.02 -3.00%
2025 $-0.02 -54.35%
2024 $-0.05 -58.93%
2023 $-0.12 102.30%
2022 $-0.06 -59.83%
2021 $-0.15 286.73%
2020 $-0.04 -47.38%
2019 $-0.07 22.53%
2018 $-0.06 -994.12%
2017 $0.01 -90.93%
2016 $0.08 -1,393.10%
2015 $-0.01 -31.76%
2014 $-0.01 -73.60%
2013 $-0.03 0.00%
EPS de empresas semelhantes ou concorrentes
Empresa EPS Diferença de EPS País
$3.62 -18,771.65%
DK
$15.47 -79,842.27%
US
$43.12 -222,368.04%
US
$9.62 -49,691.75%
BE
$38.32 -197,625.77%
NL